WARFARIN


Also found in: Dictionary, Thesaurus, Medical, Encyclopedia, Wikipedia.
Related to WARFARIN: heparin
AcronymDefinition
WARFARINAnticoagulant named for Wisconsin Alumni Research Foundation
Copyright 1988-2018 AcronymFinder.com, All rights reserved.
References in periodicals archive ?
By a newly established register-based cohort, unique opportunities to study interactions associated to the anticoagulant warfarin in large groups of individuals has been created.
The latest American College of Chest Physicians guideline for antithrombotic and thrombolytic therapy recommends the addition of low-dose aspirin (50-100 mg/day) to warfarin therapy in patients with mechanical heart valves at low bleeding risk (4).
He then explained that four effective Warfarin alternatives -- Dabigatran, Rivaroxaban, Apixaban, Edoxaban -- all require differential dosage depending on a number of variables.
While, CYP1A2 and CYP3A4 are involved in the biotransformation of R-isomer of warfarin (Holbrook et al., 2005) and caffeine is inhibitor of CYP1A2 (Eugster et al., 1993).
Warfarin Interactions Warfarin blocks the action of vitamin K, which the liver uses to make clotting factors.
Until that time, the only option was warfarin. Although this old standby is highly effective, its dose must be raised gradually, and patients must undergo regular testing to ensure they maintain enough anticoagulant to prevent clots without incurring unwanted bleeding.
Part of the World Health Organization Model List of Essential Medicines, (1) warfarin remains a relevant tool in the overall scope of oral anticoagulation therapy.
The researchers found that, compared with warfarin, apixaban was correlated with reduced risk of major bleeding and intracranial bleeding (adjusted hazard ratios, 0.66 and 0.4, respectively) and dabigatran was correlated with reduced risk of intracranial bleeding (adjusted hazard ratio, 0.45) among patients with atrial fibrillation.
Moreover, it was included 200 patients, 150 (75%) on Warfarin treatment and 50 (25%) on dabigatran.
Results: Before education warfarin knowledge levels were inadequate in intervention group, but it was higher after education and reached a good level.
(3,4) However, while previous case-control studies show that PPIs reduce the risk of upper GI bleeds in patients taking antiplatelet agents or NSAIDs, they do not show a statistically significant benefit for patients taking warfarin. (5,6) Further reflecting the confusion and uncertainty surrounding this issue is that while one expert consensus report recommends that patients taking dual warfarin and antiplatelet agent/NSAID therapy take a PPI to decrease the risk of upper GI bleeding, (2) other guidelines regarding anticoagulant therapy do not address this clinical question.
Patients who were under the age of 18, who had been using warfarin for less than one month, who were using amiodarone, furosemide, heparin, quinolone, metronidazole, omeprazole, sulfonylureas, phenytoin, and tricyclic anti-depressants, and who had an infection were excluded from the study.
Full browser ?